Development of novel anti-Kv 11.1 antibody-conjugated PEG–TiO(2) nanoparticles for targeting pancreatic ductal adenocarcinoma cells

Titanium dioxide (TiO(2)) has been widely used in many nanotechnology areas including nanomedicine, where it could be proposed for the photodynamic and sonodynamic cancer therapies. However, TiO(2) nanoformulations have been shown to be toxic for living cells. In this article, we report the developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sette, Angelica, Spadavecchia, Jolanda, Landoulsi, Jessem, Casale, Sandra, Haye, Bernard, Crociani, Olivia, Arcangeli, Annarosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857862/
https://www.ncbi.nlm.nih.gov/pubmed/24348091
http://dx.doi.org/10.1007/s11051-013-2111-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857862/
https://www.ncbi.nlm.nih.gov/pubmed/24348091
http://dx.doi.org/10.1007/s11051-013-2111-6

Ejemplares similares